MVA BN RSV vaccine - Bavarian Nordic
Alternative Names: Modified vaccinia ankara Bavarian Nordic respiratory syncytial virus vaccine; MVA-BN® RSV; MVA-mBN294B; Respiratory syncytial virus vaccine - Bavarian Nordic; RSV-vaccine-Bavarian-NordicLatest Information Update: 25 Jul 2023
Price :
$50 *
At a glance
- Originator Bavarian Nordic
- Class Respiratory syncytial virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Respiratory syncytial virus infections
Most Recent Events
- 22 Jul 2023 Bavarian Nordic terminates its licence with Nuance Pharma for MVA BN RSV vaccine in Chinese Mainland, Hong Kong, Macau, Taiwan, South Korea and Southeast Asia
- 22 Jul 2023 Discontinued - Phase-II for Respiratory syncytial virus infections (Prevention) in United Kingdom (IM)
- 22 Jul 2023 Discontinued - Phase-II for Respiratory syncytial virus infections (Prevention, In adults) in Belgium (IM)